SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.10.20 | Novartis buy | UBS AG | |
| 13.10.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.10.20 | Roche Neutral | Credit Suisse Group | |
| 01.10.20 | Roche buy | Jefferies & Company Inc. | |
| 30.09.20 | Roche buy | UBS AG | |
| 30.09.20 | Roche buy | Jefferies & Company Inc. | |
| 30.09.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 29.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.20 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.09.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.09.20 | Novartis Underweight | Barclays Capital | |
| 23.09.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.09.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 18.09.20 | Roche buy | UBS AG | |
| 15.09.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 14.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 10.09.20 | Novartis buy | UBS AG | |
| 04.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 02.09.20 | Roche buy | UBS AG | |
| 02.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 01.09.20 | Novartis overweight | Morgan Stanley | |
| 26.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.08.20 | Novartis Neutral | UBS AG | |
| 21.08.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 18.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 11.08.20 | Roche buy | UBS AG | |
| 10.08.20 | Roche overweight | JP Morgan Chase & Co. | |
| 10.08.20 | Roche overweight | Morgan Stanley | |
| 10.08.20 | Roche overweight | Barclays Capital | |
| 10.08.20 | Roche Outperform | Bernstein Research | |
| 10.08.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.08.20 | Roche overweight | JP Morgan Chase & Co. | |
| 30.07.20 | Roche buy | UBS AG | |
| 29.07.20 | Roche Neutral | Credit Suisse Group |